Excitement over a new antidepressant isn't premature, researchers told HealthDay after two large trials of a premature ejaculation drug proved safe and effective.
Dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI), a class of drugs typically used to treat depression and psychiatric conditions. One of the side effects is a delay in ejaculation, experts say.
Don't break out the bubbly yet, according to HealthDay, Dapoxetine isn't likely to gain Federal Drug Administration approval any time soon. Less desirable side effects like psychiatric problems, skin reactions, weight gain and loss of libido plague Dapoxetine's release.
"This is the first drug specifically developed for premature ejaculation," lead researcher Dr. Jon L. Pryor, a professor and chairman of urologic surgery at the University of Minnesota, told HealthDay. "It worked both in lengthening ejaculation time and in patients' feeling control over ejaculation and both subjects' and partners' feelings of satisfaction with intercourse." Complete findings appear in the Sept. 9 issue of The Lancet.
More troublesome than erectile dysfunction, premature ejaculation effects 21 to 33 percent of American men, according to researchers.
The study follows 2,614 men who experienced moderate to severe premature ejaculation for 12 weeks. On average, the men ejaculated a minute after penetration at the start of the study, increasing the time to 2.78 minutes among men on the 30-milligram dose and 3.32 minutes among men on the 60-milligram dose. Men on the placebo increased their ejaculation time to an average of 1.75 minutes.